Christopher Devine, MD
Ophthalmology · Cincinnati, OHNPI 1205838562
Payments from drug & device makers
Across 176 payments — averaging $3541.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche TCRC, Inc.$295K
- AstraZeneca$99K
- Boehringer Ingelheim$70K
- Regeneron$67K
- Amgen$39K
- Boehringer Ingelheim International GmbH$32K
- plus $22K from 14 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche TCRC, Inc. | 51 | $294,955 |
| AstraZeneca | 5 | $98,529 |
| Boehringer Ingelheim | 7 | $69,704 |
| Regeneron | 39 | $67,069 |
| Amgen | 3 | $39,214 |
| Boehringer Ingelheim International GmbH | 2 | $31,667 |
| GSK | 3 | $11,348 |
| Aerie Pharmaceuticals, Inc. | 1 | $5,000 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $3,543 |
| Abiomed | 7 | $605 |
| AbbVie(2 entities) | 14 | $385 |
| Genentech USA, Inc. | 13 | $306 |
| Novartis | 5 | $282 |
| Alimera Sciences, Inc. | 5 | $249 |
| Astellas Pharma US Inc | 6 | $162 |
| Regeneron Healthcare Solutions, Inc. | 5 | $123 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $99 |
| Biogen | 3 | $65 |
| Apellis Pharmaceuticals, Inc. | 2 | $44 |
| Bausch & Lomb Americas Inc. | 2 | $33 |
How this compares
$623,381 in reported general payments places this provider in the 95th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Cincinnati
- Daniel MillerCincinnati$2.3M
- Michael SnyderCincinnati$1.3M
- Christopher RiemannCincinnati$985K
- Robert SiskCincinnati$831K
- Anup KhatanaCincinnati$794K
- Robert OsherCincinnati$720K
- Haroon ChaudhryCincinnati$708K
- Robert BenzaCincinnati$224K
- Linda GreffCincinnati$168K
- Karen KlugoCincinnati$146K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.